Classification
Compound class	Antibody
Approved drug?	Yes (source: FDA (1994))

International Nonproprietary Names
INN number	INN
7200	abciximab

Synonyms

7E3 antibody

antiGPIIBIIIa

C7E3

ReoPro®

Database Links
Specialist databases
IMGT/mAb-DB	146
Other databases
PubChem SID	178103197
Search PubMed clinical trials	abciximab
Search PubMed titles	abciximab
Search PubMed titles/abstracts	abciximab
Wikipedia	Abciximab

Comments

Abciximab is a chimeric human-murine monoclonal antibody Fab (fragment antigen binding) fragment designed to target glycoprotein IIb/IIIa receptor, a key mediator of platelet aggregation and clot formation [2]. The invention of abciximab is covered by patent US5976532 [1], where its originating antibody is coded c7E3.